Novel Pharmacology of Diabetic Complications
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 2974
Special Issue Editors
Interests: translational pharmacology; novel mechanisms; biomarkers and treatments of diabetes complications; neuropathy; neuropathic pain; retinopathy
Special Issue Information
Dear Colleagues,
Diabetes mellitus (DM) is a common endocrine disease and major health problem across the globe. If left untreated, DM can lead to many health complications that adversely affect multiple organs or tissues, such as the kidney, heart, cardiovascular system, eyes, and nervous system. Common diabetic complications include nephropathy, retinopathy, neuropathy, neuropathic pain, and cardiovascular diseases, which can seriously impair quality of life and cause long-lasting disability, and they are often resistant to existing treatment, posing a huge economic burden on health systems and society.
Understanding the pathological basis of diabetes’ effects on different organ systems has become a cornerstone of the treatment of diabetic complications. This information helps researchers to identify potential novel drug targets at the molecular and cellular levels. This Special Issue focuses on understanding the novel pharmacological mechanisms that drive diabetes’ complications. In addition, novel therapies for diabetic complications, such as phytochemicals, gene therapy, RNA therapy, etc., are welcome. Papers with a molecular orientation will be considered for publication in this Special Issue, but clinical papers are discouraged by IJMS.
Dr. Lisa Lione
Dr. Richard Hulse
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes mellitus
- complication
- pathophysiology
- mechanism
- therapeutic strategies
